1. Different Expression Patterns of Toll-Like Receptor mRNAs in Blood Mononuclear Cells of IgA Nephropathy and IgA Vasculitis with Nephritis
   Ayano Saito et al, 2016, Tohoku J. Exp. Med. CrossRef
2. The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
   Barbora Knoppova et al, 2016, Front. Immunol. CrossRef
3. Expression profile of BAFF in peripheral blood from patients of IgA nephropathy: Correlation with clinical features and Streptococcus pyogenes infection
   Nuoyan Zheng et al, 2017 CrossRef
4. Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species
   Anastasia N. Vlasova et al, 2016, Veterinary Immunology and Immunopathology CrossRef
5. T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target
   Jakub Ruszkowski et al, 2018, Clin Exp Nephrol CrossRef
6. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy
   Di Liu et al, 2019, International Immunopharmacology CrossRef
7. New strategies and perspectives on managing IgA nephropathy
   Haresh Selvaskandan et al, 2019, Clin Exp Nephrol CrossRef
8. A proliferation-inducing ligand increase precedes IgA nephropathy recurrence in kidney transplant recipients
   Luis Martín-Penagos et al, 2019, Clin Transplant CrossRef
9. The role of BAFF and APRIL in rheumatoid arthritis
   Arezoo G. Shabgah et al, 2019, J Cell Physiol CrossRef
10. null
    Mohsen Nafar et al, 2015 CrossRef
11. NF-κB in inflammation and renal diseases
    Haisong Zhang et al, 2015, Cell Biosci CrossRef
12. Does the renal expression of Toll-like receptors play a role in patients with IgA nephropathy?
    Hana Ciferska et al, 2019, J Nephrol CrossRef
13. IFI27 Is a Useful Genetic Marker for Diagnosis of Immunoglobulin A Nephropathy and Membranous Nephropathy Using Peripheral Blood
    Yasuyuki Nagasawa et al, 2016, PLoS ONE CrossRef
14. null
    Mohsen Nafar et al, 2016 CrossRef
15. Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases
    Eileen Samy et al, 2017, International Reviews of Immunology CrossRef
16. Elevated hsa‐miR‐590‐3p expression down‐regulates HMGB2 expression and contributes to the severity of IgA nephropathy
    Yaling Zhai et al, 2019, J Cell Mol Med CrossRef
17. Increased Non-switched Memory B Cells are Associated with Plasmablasts, Serum IL-6 Levels and Renal Functional Impairments in IgAN Patients
    Rui Si et al, 2019, Immunological Investigations CrossRef
18. The epipharynx-kidney axis triggers glomerular vasculitis in immunoglobulin A nephropathy
    Osamu Hotta et al, 2019, Immunol Res CrossRef
19. High Pretransplant BAFF Levels and B-cell Subset Polarized towards a Memory Phenotype as Predictive Biomarkers for Antibody-Mediated Rejection
    Juan Irure-Ventura et al, 2020, IJMS CrossRef
20. New therapeutic perspectives for IgA nephropathy in children
    Alexandra Cambier et al, 2020, Pediatr Nephrol CrossRef
21. The Role of Immune Modulation in Pathogenesis of IgA Nephropathy
    Sheng Chang et al, 2020, Front. Med. CrossRef
22. BAFF is involved in the pathogenesis of IgA nephropathy by activating the TRAF6/NF‑κB signaling pathway in glomerular mesangial cells
    Yingjie Cao et al, 2019, Mol Med Report CrossRef
23. Toll-Like Receptor as a Potential Biomarker in Renal Diseases.
    Sebastian Mertowski et al, 2020, Int J Mol Sci CrossRef
24. BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid
    Mahya Eslami et al, 2020, Front. Cell Dev. Biol. CrossRef
25. The significance of Toll-like receptors in selected nephropathies
    Sebastian Mertowski et al, 2019, diagn lab CrossRef
26. Toll-like Receptors as Potential Therapeutic Targets in Kidney Diseases
    Qian Ren et al, 2020, CMC CrossRef
27. An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective
    Xin Huang et al, 2021, Front. Pharmacol. CrossRef
28. Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy
    Gabriella Lauriero et al, 2021, Front. Immunol. CrossRef
29. Single-cell RNA-sequencing reveals distinct immune cell subsets and signaling pathways in IgA nephropathy
    Honghui Zeng et al, 2021, Cell Biosci CrossRef
30. Increased gene expression of B cell‐activating factor of tumor necrosis factor family, in remitting antineutrophil cytoplasmic antibody‐associated vasculitis patients
    Saket Jha et al, 2021, Int J of Rheum Dis CrossRef
31. Interleukin-33 Exacerbates IgA Glomerulonephritis in Transgenic Mice Overexpressing B Cell Activating Factor
    Yuan Min Wang et al, 2022, JASN CrossRef
32. New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies
    Dita Maixnerova et al, 2022, JCM CrossRef
33. New-onset IgA nephropathy following COVID-19 vaccination
    Y Ma et al, 2022 CrossRef
34. Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy
    Toshiki Kano et al, 2022, Biomedicines CrossRef
35. Role of Palatine Tonsil and Epipharyngeal Lymphoid Tissue in the Development of Glomerular Active Lesions (Glomerular vasculitis) in Immunoglobulin A Nephropathy
    Osamu Hotta et al, 2022, IJMS CrossRef
36. New insights into the mucosal immune pathogenesis of IgA nephropathy from the perspective of COVID-19 vaccination
    Yaohui Ma et al, 2023 CrossRef
37. Identification of key genes for IgA nephropathy based on machine learning algorithm and correlation analysis of immune cells
    Suzhi Chen et al, 2023, Transplant Immunology CrossRef
38. Omics are Getting Us Closer to Understanding IgA Nephropathy
    Krzysztof Mucha et al, 2023, Arch. Immunol. Ther. Exp. CrossRef
39. The role of toll-like receptors (TLRs) and their therapeutic applications in glomerulonephritis
    Feiyan Liu et al, 2023, Int Urol Nephrol CrossRef
40. Immune abnormalities in IgA nephropathy
    Micaela Gentile et al, 2023 CrossRef
41. Emerging role of monoclonal antibodies in the treatment of IgA nephropathy
    Dita Maixnerova et al, 2023, Expert Opinion on Biological Therapy CrossRef
42. Telitacicept for autoimmune nephropathy
    Jingjing Cai et al, 2023, Front. Immunol. CrossRef
43. Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases
    Xinyin Liu et al, 2023, Front. Immunol. CrossRef
44. A narrative review of potential drug treatments for nephritis in children with IgA vasculitis (HSP)
    Chloe E C Williams et al, 2023, Clin Rheumatol CrossRef
45. Role of telitacicept in the treatment of IgA nephropathy
    Lijun Wu et al, 2023, Eur J Med Res CrossRef
46. IgA nephropathy
    Eleni Stamellou et al, 2023, Nat Rev Dis Primers CrossRef
47. The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies
    Chee Kay Cheung et al, 2024, Front. Nephrol. CrossRef
48. Successful pregnancy in a patient with IgA nephropathy treated with telitacicept: a case report
    Xinru Du et al, 2024, BMC Pregnancy Childbirth CrossRef
49. IgA Nephropathy: Emerging Mechanisms of Disease
    Lydia E. Roberts et al, 2024, IJN CrossRef
50. Targeting APRIL in the treatment of glomerular diseases
    Chee Kay Cheung et al, 2024, Kidney International CrossRef
51. Efficacy and Safety of Telitacicept in IgA Nephropathy: A Retrospective, Multicenter Study
    Lijun Liu et al, 2024, Nephron CrossRef
52. Lessons from IgA Nephropathy Models
    Toshiki Kano et al, 2024, IJMS CrossRef
53. Immunoglobulin A Antibodies: From Protection to Harmful Roles
    Patrick J. Gleeson et al, 2024, Immunological Reviews CrossRef
54. The Latest Progress in the Application of Telitacicept in Autoimmune Diseases
    Baocheng Liu et al, 2024, DDDT CrossRef
55. Glomérulonéphrite primitive à dépôts mésangiaux d’immunoglobulines A
    E. Pillebout et al, 2018, EMC - Néphrologie CrossRef